Document Detail


Concise guidance: diagnosis and management of giant cell arteritis.
MedLine Citation:
PMID:  20849016     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Giant cell arteritis (GCA) or temporal arteritis (TA) with polymyalgia rheumatica (PMR) is among the most common reasons for long-term steroid prescription. GCA is a critically ischaemic disease, the most common form of vasculitis and should be treated as a medical emergency. Visual loss occurs in up to a fifth of patients, which may be preventable by prompt recognition and treatment. The British Society for Rheumatology (BSR) and the British Health Professionals in Rheumatology (BHPR) have recently published guidelines on the management of PMR. The purpose of this concise guidance is to draw attention to the full guidelines to encourage the prompt diagnosis and urgent management of GCA, with emphasis on the prevention of visual loss. They provide a framework for disease assessment, immediate treatment and referral to specialist care for management and monitoring of disease activity, complications and relapse.
Authors:
Bhaskar Dasgupta;
Related Documents :
6421976 - Pulsating exophthalmos associated with neurofibromatosis.
3297316 - Early parkinsonism.
21971266 - Porcine xenograft biosynthetic wound dressings for the management of postoperative mohs...
6474546 - The terminology of transient visual loss due to vascular insufficiency.
12161896 - General medicine--revisited, rejuvenated, revitalized and reemphasized.
11809086 - The role of telemedicine in the assessment of strabismus.
Publication Detail:
Type:  Journal Article; Practice Guideline    
Journal Detail:
Title:  Clinical medicine (London, England)     Volume:  10     ISSN:  1470-2118     ISO Abbreviation:  Clin Med     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-09-20     Completed Date:  2010-11-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101092853     Medline TA:  Clin Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  381-6     Citation Subset:  IM    
Affiliation:
Essex University Southend University Hospital, Westcliff-on-Sea, Essex. bhaskar.dasgupta@southend.nhs.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aspirin / therapeutic use
Blindness / etiology,  prevention & control
Diagnosis, Differential
Diagnostic Imaging
Early Diagnosis
Giant Cell Arteritis / complications,  diagnosis*,  therapy*
Glucocorticoids / therapeutic use
Humans
Platelet Aggregation Inhibitors / therapeutic use
Stroke / etiology,  prevention & control
Temporal Arteries / pathology
Chemical
Reg. No./Substance:
0/Glucocorticoids; 0/Platelet Aggregation Inhibitors; 50-78-2/Aspirin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Medical professionalism: what does the public think?
Next Document:  Consultation skills training for specialist trainees.